Andrew David Levin - Executive Chairman, Director at Eliem Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Director
Stock Symbol
ELYM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew David Levin since 9/17/2023

Holdings reported by Andrew David Levin for Eliem Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right To Buy) 10K Jun 26, 2024 Direct Common Stock

Transactions reported by Andrew David Levin for Eliem Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.